Literature DB >> 4058472

Mitral valve prolapse in myotonic dystrophy.

E W Streib, D G Meyers, S F Sun.   

Abstract

Forty-three patients with myotonic dystrophy (MyD) and 43 age- and sex-matched controls were prospectively evaluated for mitral valve prolapse (MVP) using both cardiac auscultation and echocardiography (ECHO). Prevalence of MVP was significantly increased in MyD patients when using either abnormal auscultation plus abnormal ECHO (23.3%, P less than 0.02) or abnormal ECHO alone (30%, P less than 0.01) as diagnostic criteria for MVP. Frequency of MVP was even more increased in patients with a thin, flat chest compared with patients with normal physical appearance (P less than 0.007). These findings are in support of the concept that the increased frequency of MVP in neuromuscular disorders is likely due to geometrical changes of the heart caused by thorax deformities, rather than structural changes of the mitral valve. For this reason, MVP in MyD probably belongs to the entity of so-called benign, secondary MVP. This is further supported by the absence of symptoms of "systemic" complications of MVP in our patient population.

Entities:  

Mesh:

Year:  1985        PMID: 4058472     DOI: 10.1002/mus.880080804

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Electrocardiographic findings in myotonic dystrophy.

Authors:  B O Olofsson; H Forsberg; S Andersson; P Bjerle; A Henriksson; I Wedin
Journal:  Br Heart J       Date:  1988-01

2.  Cardiac involvement in congenital myotonic dystrophy.

Authors:  H Forsberg; B O Olofsson; A Eriksson; S Andersson
Journal:  Br Heart J       Date:  1990-02

3.  Left ventricular diastolic function in congenital myotonic dystrophy.

Authors:  F A Bu'Lock; M Sood; J V De Giovanni; S H Green
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

4.  Intestinal pseudo-obstruction in myotonic dystrophy.

Authors:  H G Brunner; B C Hamel; P Rieu; C J Höweler; F T Peters
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.